Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    ABBV-221
Show Display Options
Rank Status Study
1 Recruiting A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Conditions: Head and Neck Squamous Cell Carcinoma;   Non-small Cell Lung Cancer;   Triple Negative Breast Cancer;   Colorectal Carcinoma;   Glioblastoma Multiforme
Intervention: Drug: ABBV-221

Study has passed its completion date and status has not been verified in more than two years.